智通财经APP获悉，周三，联合治疗(UTHR.US)大涨超12%，续创历史新高，报465.38美元。消息面上，10月29日，该公司公布2025年第三季度业绩，每股收益7.16美元，超出分析师预期约0.16美元，净利润达3.387亿美元，同比增长约9.6%。主要产品Tyvaso报告持续两位数增长，推动总收入创纪录达7.995亿美元同比增7%，反映高市场需求。
智通财经APP获悉，周三，联合治疗(UTHR.US)大涨超12%，续创历史新高，报465.38美元。消息面上，10月29日，该公司公布2025年第三季度业绩，每股收益7.16美元，超出分析师预期约0.16美元，净利润达3.387亿美元，同比增长约9.6%。主要产品Tyvaso报告持续两位数增长，推动总收入创纪录达7.995亿美元同比增7%，反映高市场需求。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.